BioWorld: Thinking on a global scale, Gylden Vaccines using lessons from Ebola outbreak

LONDON – The lessons of the Ebola epidemic have come together with a series of scientific advances, and expertise acquired over a lifetime in biotech, to inspire a novel vaccine technology that is designed to provide genus-wide protection against viral infections.